CA has been reported to inhibit cell proliferation through cell cycle arrest at the G0/G1 phase in melanoma cancer [25], at the G2 phase in human glioma [26], and at the G1 phase in estrogen receptor (ER)-negative human breast cancer cells [27]. This evidence concerns the gene ESR1 and glioma.